RAND Review: Fall 1999

On the Cover
Capsules of Norvir, one of the first three protease inhibitors approved for treatment of the human immunodeficiency virus (HIV), roll off the manufacturing line at Abbot Laboratories in Chicago, Ill., in February 1996. Protease inhibitors are members of the new class of antiretroviral medications that have made HIV infection a highly treatable disease for those receiving appropriate care.


Fall 1999 Contents

Message from the Editor


    Patients' rights, faint lights Healthy egg, wealthy chicken Insurance for children Care for chronic illnesses Higher mandates for business and industry Culture for America Fading futures for Russia, North Korea, Indonesia

Crowding Out

Small classes teach a lesson in unintended consequences

Cover Story
Privileged Treatment

Inequities in HIV care demand remedies for U.S. health care
by Martin Shapiro and
Samuel Bozzette

Chronic Condition

Quality deficiencies pervade U.S. health care system

Math over Myth

Is drug prevention worth the price?

RAND Review is published periodically by RAND, a nonprofit institution that helps improve policy and decisionmaking through research and analysis. Opinions are those of the authors and do not reflect positions taken by RAND, its board, or its sponsors. For permission to use material published in the RAND Review, visit www.rand.org/pubs/permissions.html. Submit letters to Editor, RAND Review, 1700 Main Street, P.O. Box 2138, Santa Monica, CA 90407-2138, or e-mail godges@rand.org.

John Godges

Assistant Editor
Christina Pitcher

Miriam Polon

Art Director
Ronald Miller

Peter Soriano

Diane Baldwin

Christine Troncoso

Editorial Board

Dominic Brewer
David Chu
Paul Davis
David Gompert
Jerrold Green
James Hosek
Iao Katagiri
Kevin McCarthy
Elizabeth McGlynn
C. Richard Neu
Mary Vaiana

Most reports identified in this issue may be purchased from RAND's Distribution Services, 1700 Main Street, P.O. Box 2138, Santa Monica, CA 90407-2138. To place credit card orders, telephone (310) 451-7002; send a fax to (310) 451-6915; or send e-mail to order@rand.org. National Book Network (NBN) carries selected RAND titles. Contact NBN at (800) 462-6420 to determine availability. Selected bibliographies of current research are available at no charge. Abstracts of RAND documents are available for review on the World Wide Web at /search/pubs_search.html

This issue in PDF format
RAND Review Home Page
RAND Home Page